课题基金 / 基金详情

GLOBIN GENE REGULATION BY GATA-1 AND CHROMATIN

GLOBIN GENE REGULATION BY GATA-1 AND CHROMATIN
GATA-1 和染色质对球蛋白基因的调控
批准号:
2735205
负责人:
Mark C Walters
金额:
$25.55万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 2000-06-30

项目摘要

项目成果

Mark C Walters的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Globin genes are expressed exclusively in the erythroid lineage, and at distinct stages of development. The mechanisms by which the globin genes are regulated are of interest because a more detailed knowledge of the process is likely to contribute to therapies for severe hemoglobinopathies such as thalassemia and sickle cell disease, and because the globin genes are classic models of complex multigene regulation. Our long-term goal is to understand how the globin genes are expressed only in red blood cells, and how the individual genes are controlled through development. During erythroid differentiation, there is a progressive condensation of chromatin in the nucleus culminating in complete cessation of transcription; the globin genes continue to be transcribed until late in this process. We study a nuclear factor, GATA- 1, that appears to have a central role in the expression of globins and other typically erythroid genes in the terminal phase of erythroid differentiation at all stages of development. We have developed a model in which GATA-1 serves to keep globins and other erythroid genes in an active state while genes not essential for the erythroid program are repressed. To test this hypothesis we have developed an assay that uses the beta-geo reporter to distinguish effects on the level of gene expression from effects on epigenetic stability; previous studies of gene regulation have not separated these two parameters. We propose to investigate the interaction of erythroid transcriptional control elements with chromatin, using the beta-geo assay in conjunction with site- specific recombination to control for position effects. We will dissect the gamma-globin promoter, asking which elements within it regulate the level of gene expression and which counteract repression. We will continue our study of the 5'HS2 globin enhancer, in which we have shown that it acts primarily to relieve repression, and focus on the contribution of its component elements to its function. We will also analyze the role of the chromatin factor HMG-l in developmental regulation of the gamma-globin gene, and the expression of repressive chromatin proteins in the terminal phase. Ultimately we hope that these studies will lead to better understanding of developmental regulation of the globin genes and improved therapies for the hemoglobinopathies..
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing
Curing Sickle Cell Disease with CRISPR-Cas9 genome editing
Northern California Consortium for Sickle Cell Disease
Northern California Consortium for Sickle Cell Disease
海外基金